People · Operator
Named in public records as an officer, director or promoter · active 2010–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ra Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $39.6M | $994.6M | 2010 |
Douglas A. Treco at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas A. Treco on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James W. Broderick | 1 | 5 |
| Peter A Bisgaard | 1 | 3 |
| Rajeev A. Shah | 1 | 2 |
| Theodore A. Laufik | 1 | 2 |
| Markus A. Goebel | 1 | 1 |
| Lauren W. Silverman | 1 | 1 |
| Edward W. Mathers | 1 | 1 |
| Edward A. Mathers | 1 | 1 |
| Jason A. Lettman | 1 | 1 |
| Kerry A. Black | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.